Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy
Open Access
- 9 August 2021
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (11) , 4636-4645
Abstract
Rotavirus (RV) causes up to half of hospital and community acute gastroenteritis (AGE) cases in young children in Italy. Two RV vaccines, available since 2006, are human RV (HRV) and human bovine RV (HBRV). This report looks back at the implementation of RV vaccination with HRV in Italy, and at HRV current and future perspectives. Initial regional policies led to national implementation by 2018, after scientific societies’ disease awareness efforts. Following vaccination, RV hospitalizations declined significantly, and cost savings were observed. The two-dose HRV vaccine is easily administered during compulsory vaccine visits, helping increase coverage. Intussusception, a serious event in children <1 year, was reported in Italy with a rate of 33–40 per 100,000 infants. RV vaccination presents a low increased risk of intussusception after the first dose, estimated at 0.6 cases per 100,000 doses in Italy in 2019. Parents should be aware of the intussusception risk and symptoms to ensure prompt treatment. It is widely recognized that the vaccination benefits (large numbers of RV hospitalizations prevented) outweigh the risk. HRV introduction in Italy was supported by epidemiologic burden studies, healthcare provider opinions, and congress debates, which significantly contributed to implementation of RV universal routine infant vaccination in Italy. Graphical abstractKeywords
Funding Information
- GlaxoSmithKline Biologicals
This publication has 51 references indexed in Scilit:
- The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practicesBMC Pediatrics, 2012
- Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in AustriaVaccine, 2011
- Burden of rotavirus infections in Liguria, northern Italy: hospitalisations and potential savings by vaccinationEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, ItalyBMC Public Health, 2010
- Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countriesEuropean Journal of Pediatrics, 2010
- Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort studyBMC Infectious Diseases, 2010
- Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern ItalyBMC Infectious Diseases, 2010
- Mechanisms of Protection Against Rotavirus Infection and DiseaseThe Pediatric Infectious Disease Journal, 2009
- Burden of Rotavirus-Associated and Non-Rotavirus-Associated Diarrhea among Nonhospitalized Individuals in Central Italy: A 1-Year Sentinel-Based Epidemiological and Virological SurveillanceClinical Infectious Diseases, 2008
- Rotavirus and not age determines gastroenteritis severity in children: a hospital-based studyEuropean Journal of Pediatrics, 2006